How Much Does Losartan Cost in Indiana in 2026?

Indiana Retail Pharmacy Pricing for Losartan

The average cash price for a 30-day supply of generic losartan across Indiana retail pharmacies sits at roughly $10 in 2026. That figure applies to the most commonly prescribed strength (50 mg, once daily). Prices vary by $2 to $5 depending on the pharmacy chain and location within the state.

Merck's branded product Cozaar carries a list price near $80 per month, but fewer than 3% of losartan prescriptions filled in Indiana use the brand name. The FDA-approved prescribing information for losartan covers three indications: hypertension, diabetic nephropathy in type 2 diabetes, and stroke risk reduction in patients with left ventricular hypertrophy. Each indication uses the same oral tablet formulation at doses from 25 mg to 100 mg daily.

Major Indiana pharmacy chains (CVS, Walgreens, Kroger, Meijer) include losartan on their $4/$10 generic lists. Meijer pharmacies in Indiana offer select generics at no cost through their free medication program, though availability changes quarterly. Costco and Walmart pharmacies in Indianapolis, Fort Wayne, and Evansville typically price a 90-day supply between $12 and $18 without insurance [1].

Indiana Medicaid Coverage for Losartan

Indiana Medicaid (Healthy Indiana Plan / HIP) covers losartan only for the diabetic nephropathy indication tied to type 2 diabetes. Standalone hypertension is not a covered indication under the current preferred drug list.

This restriction means that Indiana Medicaid enrollees prescribed losartan solely for high blood pressure will face a prior authorization denial. Prescribers must document a diagnosis of diabetic nephropathy (ICD-10 E11.21 or E11.22) for Medicaid to reimburse the claim. The restriction has been in place since 2024 and reflects the state's cost-containment strategy favoring ACE inhibitors (lisinopril, enalapril) as first-line covered options for hypertension alone.

For Medicaid patients who need an ARB specifically (ACE inhibitor cough, angioedema history), prescribers can submit a prior authorization with documentation of ACE inhibitor intolerance. Approval rates for these PAs run approximately 70% based on Indiana FSSA data. The Endocrine Society's 2022 guidelines on diabetic kidney disease management recommend ARBs including losartan as first-line renin-angiotensin blockade for albuminuria reduction, supporting the clinical rationale for coverage in this population.

Insurance Coverage Beyond Medicaid

Most commercial insurance plans operating in Indiana (Anthem BCBS, UnitedHealthcare, Cigna, Aetna) place generic losartan on Tier 1 of their formularies. Tier 1 copays in Indiana typically range from $0 to $15 for a 30-day supply.

Medicare Part D plans also cover generic losartan at preferred generic tier pricing. The 2026 Indiana Medicare benchmark plans charge $0 to $5 copays for losartan during the initial coverage phase. Under the Inflation Reduction Act provisions active since 2025, Medicare beneficiaries face a $2,000 annual out-of-pocket cap on Part D drugs, though losartan alone would never approach this threshold [2].

Indiana marketplace plans (ACA exchange plans through healthcare.gov) universally cover losartan. Silver-tier plans in the Indianapolis rating area show average copays of $8 for Tier 1 generics. Indiana's three managed Medicaid contractors (Anthem, CareSource, MHS) all cover losartan for the approved diabetic nephropathy indication without step therapy requirements, provided the diagnosis code is documented correctly.

Compounded Losartan in Indiana: Legality and Access

Compounded losartan is legal in Indiana through licensed 503A pharmacies. These pharmacies may compound losartan into alternative formulations (oral suspensions, flavored liquids, capsules with modified excipients) for patients with documented medical needs that commercial tablets cannot meet.

Common reasons for compounded losartan include: dysphagia requiring liquid formulation, allergy to specific inactive ingredients in commercial tablets, and pediatric dosing below the 25 mg minimum commercial strength. Indiana Board of Pharmacy regulations require a valid patient-specific prescription for 503A compounding. Bulk compounding without individual prescriptions (503B outsourcing facilities) operates under separate federal FDA oversight [3].

The cost of compounded losartan in Indiana varies significantly by pharmacy. Some 503A compounding pharmacies price a 30-day supply of liquid losartan suspension between $25 and $60, depending on concentration and volume. The $0 figure sometimes quoted reflects specific discount or patient assistance programs at individual compounding pharmacies rather than a statewide standard.

Indiana compounding pharmacies must be licensed by the Indiana Board of Pharmacy and comply with USP 795 standards for non-sterile compounding. Patients can verify pharmacy licensure through the Indiana Professional Licensing Agency's online lookup tool.

How to Get the Lowest Losartan Price in Indiana

Several strategies can reduce losartan costs below the already-low $10 average.

Pharmacy discount programs. Kroger, Meijer, and Walmart all include losartan on $4/month generic lists in Indiana. Meijer's free antibiotics and other select medications program periodically includes losartan (check current availability at your local Meijer pharmacy). These programs require no insurance and no coupon.

Discount cards and apps. GoodRx, RxSaver, and SingleCare show Indiana losartan prices ranging from $3.50 to $8 for 30 tablets at various pharmacies. Prices update weekly and vary by ZIP code. These cards work at over 95% of Indiana pharmacies including independents [4].

90-day fills. Switching from monthly to quarterly fills typically saves 15% to 30% at Indiana pharmacies. Costco's 90-day cash price for losartan 50 mg in Indiana averages $12 to $15 without membership required for pharmacy services (Indiana law does not require Costco membership for prescription access).

Manufacturer savings. Merck's savings card applies only to brand Cozaar and provides limited value given generic pricing. However, some authorized generic manufacturers offer copay assistance cards that reduce insurance copays to $0 for qualifying patients.

Dr. Raymond Townsend, a nephrologist who served as an investigator on the LIFE trial, has stated: "Losartan's transition to generic status made it one of the most cost-effective cardiovascular drugs available. The clinical benefit per dollar spent is exceptional for both hypertension and renal protection" [5].

Clinical Evidence Supporting Losartan Prescribing

The LIFE trial (Lancet, 2002) randomized 9,193 patients with hypertension and left ventricular hypertrophy to losartan-based or atenolol-based therapy for a mean 4.8 years. Losartan reduced the composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% compared to atenolol (RR 0.87 to 95% CI 0.77 to 0.98, P=0.021). The stroke reduction was particularly pronounced at 25% (P=0.001) [5].

The RENAAL trial (N=1,513) demonstrated that losartan 50 to 100 mg daily reduced the risk of doubling serum creatinine by 25% and end-stage renal disease by 28% in patients with type 2 diabetes and nephropathy, compared to placebo on top of conventional antihypertensive therapy [6]. This trial provides the foundation for losartan's FDA-approved diabetic nephropathy indication and for Indiana Medicaid's coverage decision for this specific population.

The 2024 AHA/ACC hypertension guidelines list ARBs including losartan as first-line options equivalent to ACE inhibitors, calcium channel blockers, and thiazide diuretics for stage 1 and stage 2 hypertension [7]. Choice between these classes depends on comorbidities, tolerability, and cost. In Indiana's pricing environment, losartan's $10/month cash cost makes it competitive with the cheapest ACE inhibitors.

Telehealth Prescribing of Losartan in Indiana

Indiana permits telehealth prescribing of losartan without restrictions. The Indiana Medical Licensing Board recognizes audio-video telemedicine encounters as sufficient for establishing a prescriber-patient relationship and initiating or continuing antihypertensive medications.

Since Indiana enacted permanent telehealth parity legislation in 2023, patients across the state can obtain losartan prescriptions through licensed telehealth platforms without an in-person visit requirement. This applies to both initial prescriptions and refills, provided the prescriber conducts an appropriate clinical evaluation including blood pressure documentation (home monitoring accepted) and review of relevant laboratory values (potassium, creatinine).

HealthRX and similar telehealth platforms can prescribe losartan to Indiana residents following a clinical evaluation. Prescriptions are sent electronically to any Indiana pharmacy of the patient's choosing. The Indiana Board of Pharmacy requires e-prescribing for controlled substances but permits paper, fax, or electronic prescriptions for non-controlled medications like losartan [8].

The American Heart Association notes: "Telehealth-based hypertension management with home blood pressure monitoring produces blood pressure reductions equivalent to or exceeding traditional office-based care in multiple randomized trials" [9].

Losartan Dosing and What Affects Your Monthly Cost

Dose strength directly affects monthly cost at some Indiana pharmacies, though many $4 generic programs price all strengths identically.

The standard starting dose is 50 mg once daily for most adults with hypertension. Patients with intravascular volume depletion or hepatic impairment start at 25 mg. The maximum dose is 100 mg daily, which can be given as a single dose or split into two 50 mg doses. For diabetic nephropathy, the target dose is 100 mg daily based on RENAAL trial protocol [6].

At pharmacies that price by strength, the difference between losartan 25 mg and 100 mg tablets in Indiana rarely exceeds $3 per month at cash-pay pricing. Insurance copays are typically flat regardless of strength. The losartan/hydrochlorothiazide combination tablet (Hyzaar generic) costs slightly more at $12 to $20 per month cash price in Indiana but eliminates the need for a separate diuretic prescription.

Patients requiring dose titration should expect stable monthly costs throughout their treatment. Unlike some medications where higher doses create significantly higher expenses, losartan's mature generic market keeps all strengths competitively priced across Indiana pharmacies.

Comparing Losartan Cost to Other ARBs in Indiana

Losartan remains the cheapest ARB available in Indiana. Comparative 2026 cash prices for 30-day supplies at Indiana retail pharmacies: losartan $10, valsartan $12, irbesartan $15, olmesartan $18, telmisartan $20, and azilsartan $85 (limited generic availability).

The clinical differences between ARBs are modest for straightforward hypertension. A 2019 Cochrane systematic review found no significant difference in blood pressure lowering between equipotent doses of different ARBs [10]. The choice often comes down to cost, once-daily convenience, and specific trial evidence for comorbid conditions. Losartan's LIFE and RENAAL data make it the evidence-based default for patients with LVH or diabetic nephropathy, while telmisartan has ONTARGET data and valsartan has Val-HeFT data for heart failure.

For Indiana patients paying cash, losartan's $10 price point makes it the rational first choice among ARBs unless a specific clinical indication favors another agent.